Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of K0706 in Subjects With Early Parkinson's Disease

Next Previous
Trial Profile

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of K0706 in Subjects With Early Parkinson's Disease

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 30 Nov 2018

At a glance

  • Drugs SUN K706 (Primary)
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Sponsors Sun Pharma Advanced Research Company

    • Most Recent Events

    • 06 Nov 2018 Planned initiation date changed from 1 Oct 2018 to 1 Dec 2018.
    • 06 Sep 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top